RE:RE:RE:Second Wolfofoakville analysis since April 2023Rainy day here in ON so I have been reading some of his reviews. Love his sense of humour. He's pretty stingy with his rating stars. He seems to call them as he sees them. The Well Health review was a good example. He didn't like their debt load so he sold his shares even though Well has 9 Analysts and 8 of them have a buy rating.
He is a little concerned about GSI's Q2. I had forgotten GSI had such a blow out Q2 last year with rev of $9.7m. I checked and he was right. GSI's latest news release said the completed Septa contract will add $3.5m to rev in Q1 and $5m in Q2. So we can use those numbers as the baseline. Can we do $9.7m again? I guess thats the question he has?